Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	27.91	2.69	2.11
Graham Fair Price	154.69	7538.29	2959.73
PEG	-97.55	-0.01	0.59
Price/Book	1.33	0.38	0.37
Price/Cash Flow	66.15	6.37	3.83
Prices/Earnings	-84.79	10.92	-71.80
Price/Sales	-0.28	0.70	0.70
Price/FCF	66.15	6.37	3.83
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-14.05	0.08	0.09
Operating Margin	-75.73	< 0.005	0.03
ROA	553.16	< 0.005	< 0.005
ROE	< 0.005	< 0.005	566.07
ROIC	< 0.005	< 0.005	7.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.11	90.28
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	5.47	-0.76	-86.18
EPS QOQ	-1.22	7.57	521.68
FCF QOQ	0.74	-0.40	-46.55
Revenue QOQ	-0.03	< 0.005	-91.90
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	48.13	43.28	-10.08
Days Sales Outstanding (DSO)	50.47	50.03	-0.88
Inventory Turnover	1.87	2.08	11.20
Debt/Capitalization	0.05	0.05	-0.92
Quick Ratio	2.58	2.18	-15.51
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17308.50	17081.30	-1.31
Cash	11418.18	11275.21	-1.25
Capex	-499.33	-741.27	-48.45
Free Cash Flow	1684.88	1014.05	-39.81
Revenue	9250.65	9276.85	0.28
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.30	2.78	-15.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.99	-2.12	-6.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating